SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry

被引:4
作者
Sakurai, Yasuteru [1 ,2 ,3 ]
Okada, Sayaka [2 ]
Ozeki, Takehiro [2 ,4 ]
Yoshikawa, Rokusuke [1 ,2 ]
Kinoshita, Takaaki [2 ]
Yasuda, Jiro [1 ,2 ,3 ,4 ]
机构
[1] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Emerging Infect Dis, Nagasaki, Japan
[2] Nagasaki Univ, Natl Res Ctr Control & Prevent Infect Dis CCPID, Dept Emerging Infect Dis, Nagasaki, Japan
[3] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan
[4] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan
基金
日本学术振兴会;
关键词
SARS-CoV-2; Omicron; adaptation; spike; host cell entry; INFECTION; SPIKE;
D O I
10.1128/msphere.00338-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant exhibits high transmissibility with a strong immune escape ability and causes frequent large-scale global infections by producing predominant subvariants. Here, using human upper/lower airway and intestinal cells, we examined the previously dominant BA.1-BA.5 and BA.2.75 subvariants, together with the recently emerged XBB/BQ lineages, in comparison to the former Delta variant. We observed a tendency for each virus to demonstrate higher growth capability than the previously dominant subvariants. Unlike human bronchial and intestinal cells, nasal epithelial cells accommodated the efficient entry of certain Omicron subvariants, similar to the Delta variant. In contrast to the Delta's reliance on cell-surface transmembrane protease serine 2, all tested Omicron variants depended on endosomal cathepsin L. Moreover, S1/S2 cleavage of early Omicron spikes was less efficient, whereas recent viruses exhibit improved cleavage efficacy. Our results show that the Omicron variant progressively adapts to human cells through continuous endosome-mediated host cell entry.IMPORTANCESARS-CoV-2, the causative agent of coronavirus disease 2019, has evolved into a number of variants/subvariants, which have generated multiple global waves of infection. In order to monitor/predict virological features of emerging variants and determine appropriate strategies for anti-viral development, understanding conserved or altered features of evolving SARS-CoV-2 is important. In this study, we addressed previously or recently predominant Omicron subvariants and demonstrated the gradual adaptation to human cells. The host cell entry route, which was altered from the former Delta variant, was conserved among all tested Omicron subvariants. Collectively, this study revealed both changing and maintained features of SARS-CoV-2 during the Omicron variant evolution. SARS-CoV-2, the causative agent of coronavirus disease 2019, has evolved into a number of variants/subvariants, which have generated multiple global waves of infection. In order to monitor/predict virological features of emerging variants and determine appropriate strategies for anti-viral development, understanding conserved or altered features of evolving SARS-CoV-2 is important. In this study, we addressed previously or recently predominant Omicron subvariants and demonstrated the gradual adaptation to human cells. The host cell entry route, which was altered from the former Delta variant, was conserved among all tested Omicron subvariants. Collectively, this study revealed both changing and maintained features of SARS-CoV-2 during the Omicron variant evolution.
引用
收藏
页数:16
相关论文
共 61 条
[1]   The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype [J].
Barut, G. Tuba ;
Halwe, Nico Joel ;
Taddeo, Adriano ;
Kelly, Jenna N. ;
Schoen, Jacob ;
Ebert, Nadine ;
Ulrich, Lorenz ;
Devisme, Christelle ;
Steiner, Silvio ;
Trueeb, Bettina Salome ;
Hoffmann, Bernd ;
Veiga, Ines Berenguer ;
Leborgne, Nathan Georges Francois ;
Moreira, Etori Aguiar ;
Breithaupt, Angele ;
Wylezich, Claudia ;
Hoeper, Dirk ;
Wernike, Kerstin ;
Godel, Aurelie ;
Thomann, Lisa ;
Flueck, Vera ;
Stalder, Hanspeter ;
Bruegger, Melanie ;
Esteves, Blandina I. Oliveira ;
Zumkehr, Beatrice ;
Beilleau, Guillaume ;
Kratzel, Annika ;
Schmied, Kimberly ;
Ochsenbein, Sarah ;
Lang, Reto M. ;
Wider, Manon ;
Machahua, Carlos ;
Dorn, Patrick ;
Marti, Thomas M. ;
Funke-Chambour, Manuela ;
Rauch, Andri ;
Widera, Marek ;
Ciesek, Sandra ;
Dijkman, Ronald ;
Hoffmann, Donata ;
Alves, Marco P. ;
Benarafa, Charaf ;
Beer, Martin ;
Thiel, Volker .
NATURE COMMUNICATIONS, 2022, 13 (01)
[2]   Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron [J].
Carreno, Juan Manuel ;
Alshammary, Hala ;
Tcheou, Johnstone ;
Singh, Gagandeep ;
Raskin, Ariel J. ;
Kawabata, Hisaaki ;
Sominsky, Levy A. ;
Clark, Jordan J. ;
Adelsberg, Daniel C. ;
Bielak, Dominika A. ;
Gonzalez-Reiche, Ana Silvia ;
Dambrauskas, Nicholas ;
Vigdorovich, Vladimir ;
Srivastava, Komal ;
Sather, D. Noah ;
Sordillo, Emilia Mia ;
Bajic, Goran ;
van Bakel, Harm ;
Simon, Viviana ;
Krammer, Florian .
NATURE, 2022, 602 (7898) :682-+
[3]   Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters [J].
Case, James Brett ;
Scheaffer, Suzanne M. ;
Darling, Tamarand L. ;
Bricker, Traci L. ;
Adams, Lucas J. ;
Harastani, Houda H. ;
Trende, Reed ;
Sanapala, Shilpa ;
Fremont, Daved H. ;
Boon, Adrianus C. M. ;
Diamond, Michael S. .
JOURNAL OF VIROLOGY, 2023, 97 (09) :e0062823
[4]   Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization [J].
Cele, Sandile ;
Jackson, Laurelle ;
Khoury, David S. ;
Khan, Khadija ;
Moyo-Gwete, Thandeka ;
Tegally, Houriiyah ;
San, James Emmanuel ;
Cromer, Deborah ;
Scheepers, Cathrine ;
Amoako, Daniel G. ;
Karim, Farina ;
Bernstein, Mallory ;
Lustig, Gila ;
Archary, Derseree ;
Smith, Muneerah ;
Ganga, Yashica ;
Jule, Zesuliwe ;
Reedoy, Kajal ;
Hwa, Shi-Hsia ;
Giandhari, Jennifer ;
Blackburn, Jonathan M. ;
Gosnell, Bernadett, I ;
Karim, Salim S. Abdool ;
Hanekom, Willem ;
von Gottberg, Anne ;
Bhiman, Jinal N. ;
Lessells, Richard J. ;
Moosa, Mahomed-Yunus S. ;
Davenport, Miles P. ;
de Oliveira, Tulio ;
Moore, Penny L. ;
Sigal, Alex .
NATURE, 2022, 602 (7898) :654-+
[5]   Long COVID: major findings, mechanisms and recommendations [J].
Davis, Hannah E. ;
McCorkell, Lisa ;
Vogel, Julia Moore ;
Topol, Eric J. .
NATURE REVIEWS MICROBIOLOGY, 2023, 21 (03) :133-146
[6]   SARS-CoV-2 Omicron variant: recent progress and future perspectives [J].
Fan, Yao ;
Li, Xiang ;
Zhang, Lei ;
Wan, Shu ;
Zhang, Long ;
Zhou, Fangfang .
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
[7]   Convergent Evolution in SARS-CoV-2 Spike Creates a Variant Soup from Which New COVID-19 Waves Emerge [J].
Focosi, Daniele ;
Quiroga, Rodrigo ;
McConnell, Scott ;
Johnson, Marc C. ;
Casadevall, Arturo .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
[8]  
Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]
[9]   Transmission and re-infection of Omicron variant XBB.1.5 in hamsters [J].
Halfmann, Peter J. ;
Uraki, Ryuta ;
Kuroda, Makoto ;
Iwatsuki-Horimoto, Kiyoko ;
Yamayoshi, Seiya ;
Ito, Mutsumi ;
Kawaoka, Yoshihiro .
EBIOMEDICINE, 2023, 93
[10]   Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2 [J].
Hatton, Catherine F. ;
Botting, Rachel A. ;
Duenas, Maria Emilia ;
Haq, Iram J. ;
Verdon, Bernard ;
Thompson, Benjamin J. ;
Spegarova, Jarmila Stremenova ;
Gothe, Florian ;
Stephenson, Emily ;
Gardner, Aaron I. ;
Murphy, Sandra ;
Scott, Jonathan ;
Garnett, James P. ;
Carrie, Sean ;
Powell, Jason ;
Khan, C. M. Anjam ;
Huang, Lei ;
Hussain, Rafiqul ;
Coxhead, Jonathan ;
Davey, Tracey ;
Simpson, A. John ;
Haniffa, Muzlifah ;
Hambleton, Sophie ;
Brodlie, Malcolm ;
Ward, Chris ;
Trost, Matthias ;
Reynolds, Gary ;
Duncan, Christopher J. A. .
NATURE COMMUNICATIONS, 2021, 12 (01)